Navigation Links
Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom
Date:12/16/2009

HOUSTON, Dec. 16 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced Alison Davies as its new Director of Sales in the UK. Ms. Davies has spent the last fourteen years of her professional career in the dental industry, most recently for nine years as a senior manager with Align Technology, makers of Invisalign.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients wear in the mouth for twenty minutes daily to accelerate orthodontic tooth movement. Last month, the original inventor of the AcceleDent technology, Jeremy Mao, DDS, PhD, completed a lecture tour in London which included two prestigious academic institutions, as well as an audience of orthodontic specialists at their annual conference. The product was introduced to the UK in September, and the first patient in private practice was treated there in October.

Ms. Davies, who also holds a Diploma in Dental Hygiene and a BTec in Dental Technology, both from the University of Cardiff, noted, "Introducing a new product category will come with many challenges; launching innovation always does. An exciting benefit of AcceleDent is that it can be used to enhance orthodontic treatment of any approach, regardless of the type of appliance or profile of patient."

OrthoAccel is presently controlling availability of AcceleDent in the United Kingdom to a select group of orthodontic specialists before a broader release in October 2010.

Mike Kaufman, VP Business Development and Marketing for OrthoAccel commented, "Alison is a perfect addition to our team at this important stage. Her experience, relationships, and skill serve as important assets for not only our UK plans, but also our broader pan-European market strategy over time."

OrthoAccel is nearing conclusion of another US clinical trial at the UT Health Science Center in San Antonio with an anticipated completion date during the first half of 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com or requested via info@orthoaccel.com


    Media Contact Michael K. Lowe, CEO +1 (832) 631-1659

SOURCE OrthoAccel Technologies, Inc.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quickly Identify Top-Performing Research Sites, Minimize Start-Up Timelines, Maximize Enrollment
2. Top-Performing Medical Equipment Companies Announced
3. Sustaining Excellence in All Aspects of Cardiac Care Rare But Lives Could Be Saved If More Patients Were Treated at Top-Performing Hospitals
4. Top-Performing Healthcare Software and Services Companies Announced
5. Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People
6. LogoLoft.com Posts 64% Sales Increase Over Previous Year As More Americans Start Their Own Businesses
7. Salesforce CRM Users Outperform Past Results by a Factor of at Least 50%
8. Leading Sales and Operations Planning (S&OP) Provider Steelwedge Announces i2 Exchange Program
9. FramesDirect.com Has Record-Breaking Sales on Black Friday and Cyber Monday
10. The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession
11. NBTY To Webcast Presentation; Wedbush Securities California Dreamin Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... February is Heart Awareness ... Rate Variability scans throughout the month to the American Heart Association, New Mexico chapter. ... signs of heart disease and Health Quest’s INSiGHT Pulse Wave Profiler utilizes a non-invasive ...
(Date:2/9/2016)... ... February 09, 2016 , ... A new study ... rates and Medicare rates for a variety of medical services in Illinois as ... of the 2015 Fee Schedule Rates in Illinois, are professional medical services, ...
(Date:2/9/2016)... California (PRWEB) , ... February ... ... automated print and e-book publishing software, in partnership with Snowfall4pod Digital, creators ... – a comprehensive book publishing, content management, global distribution and print-on-demand network. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Establishment Labs, a global breast implant ... to the company´s Board of Directors. , “We are honored to welcome ... exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of Establishment Labs. "David’s knowledge and ...
(Date:2/9/2016)... ... ... Journal of Pain Research has published the commentary “ Terminology of chronic ... John F. Peppin says “Terminology matters, yet little attention has been paid to the ... pain’ and ‘chronic non-cancer pain’ are replete in the literature; however, the distinction here ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
(Date:2/9/2016)... -- Amarantus BioScience Holdings, Inc. (OTCQB: ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference which ... New York City . The Company,s presentation will ... pm by Gerald E. Commissiong , President & ...
(Date:2/9/2016)... "Global Blood Monitoring & Cardiac Monitoring Devices Market Assessment & Forecast: ... global market for blood monitoring & cardiac monitoring devices was valued ... US$ 24,830.1 million by 2019 at a CAGR of 6.8% from ... Europe , Asia-Pacific , ... Africa . The three major factors determining growth of ...
Breaking Medicine Technology: